The new dry cat food that will alleviate feline hairballs is now available in stores
ACANA—a brand of Champion Petfoods—announced that its ACANA Indoor Entrée has received approval from the FDA. Through its formula made up of oat groats, miscanthus grass, lentils, chickpeas, and lentil fibers, the newly approved food helps control feline hairballs.
"Our team at ACANA pet foods is dedicated to helping cats thrive and receiving FDA approval for hairball control demonstrates our commitment to going above and beyond when it comes to food safety," said Billy Frey, director of ACANA Cat at Champion Petfoods, in a company release.1 "Pet lovers value the health and wellbeing of their feline friends, and ACANA Indoor Entrée can support regular feline hairball control."
This product is made specifically for indoor cats and contains chicken, turkey, whole herring, and rabbit. According to the release, this high protein formula will help build muscle while balancing Omega fatty acids to support a shiny coat and healthy skin.1
"When a cat regurgitates a hairball, it can negatively impact their wellbeing and result in loss of nutrition, esophageal irritation, and other potential medical problems," said Darcia Kostiuk, DVM, in-house senior veterinarian for ACANA pet food, in the release.1
"By increasing the fiber content, using oat groats, miscanthus grass, lentils, and chickpeas, ACANA Indoor Entrée improves food digestibility and aids in the reduction of feline hairball symptoms," she explained.
This FDA approval is the first for not only ACANA food, but for its parent company Champion Petfoods as well. This product is now available at Petco, Chewy, and Amazon.
Reference
ACANA® Indoor Entrée Dry Cat Food Receives FDA Approval for Hairball Control. News release. Champion Petfoods. May 18, 2022. Accessed May 19, 2022. https://prnmedia.prnewswire.com/news-releases/acana-indoor-entree-dry-cat-food-receives-fda-approval-for-hairball-control-301545962.html
Oral solution approved by the FDA for canine heart failure
November 22nd 2024Vetmedin Solution from Boehringer Ingelheim is indicated for treatment of cases caused by myxomatous mitral valve disease or dilated cardiomyopathy and is the first oral solution approved by the FDA for this use in dogs
Read More